2 results
Approved WMOWill not start
Sub-study APhase 1b:To assess the DLT rate and estimate the MTD of sasanlimab in combination with encorafenib and binimetinib to determine the RP2D for the combination. Phase 2:To assess the durable ORR of sasanlimab in combination with encorafenib…
Approved WMOWill not start
The objective of this study is to evaluate the safety and performance of the DaVingi* TR System for the treatment of patients with functional tricuspid regurgitation within its intended use.The study will:• Evaluate the safety and feasibility of…